Arcutis to Present New Quality of Life and Long-Term Data with ZORYVE® (roflumilast) Cream 0.15% and 0.05% for the Treatment of Atopic Dermatitis at the Fall Clinical ...

New data from Phase 3 studies show once-daily ZORYVE cream helped reduce sleep disruptions in individuals with atopic dermatitis aged ≥2 yearsNew ...

New drug tested in mice could fill treatment void for most severe heart attack patients

A new drug being trialed in heart attack patients could reprogram the immune system to prevent inflammation and heart damage ...